Peg-ReliGrast
Composition for Peg-ReliGrast Products
Peg-ReliGrast Products are primarily used for
Infections after chemotherapyProducts for Peg-ReliGrast
Peg-ReliGrast Injection
prefilled syringe of 1 Injection
MRP₹4847
Not Available
Substitute brands for Peg-ReliGrast
About Peg-ReliGrast Products
Uses of Peg-ReliGrast Products
Pegfilgrastim is used to prevent infections after chemotherapy.
Peg-ReliGrast Products side effects
Common
Side Effects of Peg-ReliGrast are Joint pain, Headache, Muscle pain, Back pain, Injection site pain, Hair loss, Fever, Diarrhea, Skeletal pain, Limb pain, Musculoskeletal (bone, muscle or joint) pain, Neck pain.
Severe
Side Effects of Peg-ReliGrast are Enlarged spleen, Splenic rupture, Acute respiratory distress syndrome, Hypersensitivity, Sickle cell crisis, Erythema (skin redness), Flushing (sense of warmth in the face, ears, neck and trunk), Sweet's syndrome, Capillary leak syndrome, Glomerulonephritis.
How Peg-ReliGrast Products work
Pegfilgrastim is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.
.
In Depth Information for Peg-ReliGrast Products
- Peg-ReliGrast reduces the risk of infection in people treated with chemotherapy.
- It is usually given as a daily injection into the tissue just under the skin or into the vein.
- You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
- Store it in the refrigerator, protect it from light, and don't shake it.
- For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
- Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
- Use caution while driving or doing anything that requires concentration as Peg-ReliGrast may cause dizziness.
- Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
- Stop taking Peg-ReliGrast and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.
- Peg-ReliGrast reduces the risk of infection in people treated with chemotherapy.
- It is usually given as a daily injection into the tissue just under the skin or into the vein.
- You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
- Store it in the refrigerator, protect it from light, and don't shake it.
- For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
- Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
- Use caution while driving or doing anything that requires concentration as Peg-ReliGrast may cause dizziness.
- Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
- Stop taking Peg-ReliGrast and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.
Patient Concerns about Peg-ReliGrast Products
Frequently asked questions about Peg-ReliGrast Products
Q. What is Peg-ReliGrast Injection? How is it given?
Peg-ReliGrast Injection belongs to a class of medications called colony stimulating factors. It helps reduce the chances of infections and side effects related to chemotherapy and does not directly treat cancer. It comes as a solution (liquid) to inject subcutaneously (under the skin), 24 hours after chemotherapy. It may be injected by a doctor/nurse in a hospital or you may be shown how to use injections at home
Q. How does pegfilgrastim work?
Pegfilgrastim belongs to a class of medications called colony stimulating factors. It acts on hematopoietic cells (cells in the bone marrow that produce red blood cells, white blood cells, and platelets) to increase production of neutrophils (a type of white blood cell) in the body.